A comprehensive view of Eli Lilly & Co.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
Lilly Recommends Shareholders Reject 'Mini-Tender' Offer by Tutanota LLC
Published:
April 26, 2024
by Eli Lilly & Co.
|
European Patent Office Publishes Eli Lilly and Company's Patent Application for 2019 Novel Coronavirus Antibody-Containing Pharmaceutical Formulations
Published:
April 25, 2024
by Pharmaceutical Patent News
|
Eli Lilly and Company Submits European Patent Application for Peptides Comprising N-Formyl-Halogenated Methionine Residues and Engineered Antibody-Peptide Conjugates Thereof
Published:
April 25, 2024
by Biotechnology Patent News
|
US Patent Issued to ELI LILLY and Co. on April 23 for "Compounds useful for inhibiting RET kinase" (Colorado, Montana Inventors)
Published:
April 24, 2024
by U.S. Fed News
|
INTERNATIONAL PATENT: ELI LILLY AND COMPANY FILES APPLICATION FOR "SYNTHESIS OF 6-FLUORO-2-METHYLBENZO[D]THIAZOL-5-YL COMPOUNDS"
Published:
April 23, 2024
by U.S. Fed News
|
Ask us about our Tissue & Hygiene market view